Resfriol D Tablet
Product Images NDC 69729-323

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Resfriol D (NDC 69729-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opmx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rd144 (Resfriol D 144)

Packaging label for RESFRIOL D tablets with 144 count. The label highlights the active ingredients: Acetaminophen 500 mg, Chlorpheniramine Maleate 4 mg, and Phenylephrine HCl 10 mg. It is a human OTC drug for oral use, distributed by OPMX LLC San Diego, CA. The label includes bilingual Spanish and English text describing cold/allergy relief and drug facts.*

FDA Label Image

Rd12 (Resfriol D 12)

RESFRIOL D cold/allergy relief tablets packaging label features acetaminophen 500 mg, chlorpheniramine maleate 4 mg, and phenylephrine HCl 10 mg. The package contains 12 tablets in 6 pouches of 2 tablets each. Labeler information shows OPMX LLC, with directions and drug facts included on the carton. The design includes bilingual symptom relief details in English and Spanish.*

FDA Label Image

Rd2 (Resfriol D 2)

Label for RESFRIOL D tablets, containing Acetaminophen 500 mg, Chlorpheniramine Maleate 4 mg, and Phenylephrine HCl 10 mg. The label highlights cold and allergy relief uses, listing symptoms like headache, nasal congestion, sneezing, and itchy, watery eyes. It includes bilingual text in English and Spanish and is distributed by OPMX LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.